| systematic review | Q1504425 |
| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Yousra A Mohamoud | Q91165571 |
| Laith J Abu-Raddad | Q37607654 | ||
| P2093 | author name string | Suzanne Riome | |
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Epidemiology of hepatitis C virus infection | Q22305500 | ||
| The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis | Q26795711 | ||
| HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis | Q27013667 | ||
| Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysis? | Q43035435 | ||
| High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies | Q43038016 | ||
| Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease | Q43039354 | ||
| Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications | Q43041311 | ||
| Importing health conditions of expatriate workers into the United Arab Emirates | Q43773103 | ||
| beta-Thalassaemia major in Kuwait | Q44454429 | ||
| Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias | Q45787155 | ||
| Hepatitis C virus antibodies in high-risk Saudi groups | Q45854294 | ||
| Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection | Q47582698 | ||
| Disease markers in blood donors at King Fahad Hospital, Al Baha. | Q47828255 | ||
| Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C). | Q48117224 | ||
| Prevalence of viral markers among first-time Arab blood donors in Kuwait. | Q54302986 | ||
| Infection with hepatitis viruses (B and C) and human retroviruses (HTLV-1 and HIV) in Saudi children receiving cycled cancer chemotherapy. | Q55240723 | ||
| Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major | Q27469330 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses | Q28087794 | ||
| Transformations Related to the Angular and the Square Root | Q29397126 | ||
| Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
| Evolving epidemiology of hepatitis C virus | Q29619973 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options | Q29620126 | ||
| A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Q30403548 | ||
| The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis | Q30651560 | ||
| The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt | Q33884428 | ||
| Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt | Q34093173 | ||
| Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis | Q34134485 | ||
| Global distribution and prevalence of hepatitis C virus genotypes | Q34431175 | ||
| Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial | Q34649453 | ||
| Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa | Q34761973 | ||
| An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt | Q34903996 | ||
| Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt | Q35194411 | ||
| Hepatitis C virus (HCV) infection in Saudi Arabia: A review | Q36766362 | ||
| Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa | Q36891872 | ||
| Epidemiology of HIV infection in the Middle East and North Africa | Q37770840 | ||
| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel | Q37886280 | ||
| HCV burden of infection in Egypt: results from a nationwide survey | Q39035521 | ||
| Interspousal and intrafamilial transmission of hepatitis C virus: a myth or a concern? | Q39151577 | ||
| Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study | Q39242992 | ||
| Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community | Q39351107 | ||
| Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia | Q40485120 | ||
| Viral hepatitis B and C in HIV-infected patients in Saudi Arabia | Q41722727 | ||
| Risk of hepatitis C virus infection among household contacts of Saudi patients with chronic liver disease | Q42978703 | ||
| Seropositivity to hepatitis C virus in Saudi haemodialysis patients | Q42981867 | ||
| Hepatitis C antibodies among blood donors in Qatar | Q42982250 | ||
| Hepatitis C in chronic renal failure patients | Q42982528 | ||
| Hepatitis C virus antibody in Kuwait | Q42983435 | ||
| Prevalence and significance of antibodies to hepatitis c virus among Saudi haemodialysis patients | Q42986046 | ||
| Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods | Q42989237 | ||
| Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial | Q42990184 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| hepatitis C | Q154869 | ||
| systematic review | Q1504425 | ||
| Hepatitis C virus | Q708693 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 116-25 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | International Journal of Infectious Diseases | Q15262334 |
| P1476 | title | Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence | |
| P478 | volume | 46 |
| Q98892424 | Accelerating the elimination of hepatitis C in Kuwait: An expert opinion |
| Q92354619 | An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman |
| Q90106891 | Characterization of the hepatitis C virus epidemic in Pakistan |
| Q47548612 | Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions |
| Q58611270 | Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan |
| Q41921995 | Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions |
| Q48286494 | Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome. |
| Q64104139 | Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study |
| Q26768490 | Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis |
| Q38607430 | Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns |
| Q59351137 | Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor? |
| Q91658051 | Hepatitis C Virus Infection in Populations With Liver-Related Diseases in the Middle East and North Africa |
| Q38372469 | Hepatitis C infection epidemiology in Mongolia: protocol of a systematic review and meta-analysis |
| Q45325371 | Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile. |
| Q45223604 | Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions |
| Q33610337 | Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan. |
| Q59361086 | Prevalence of hepatitis B, C, and HIV among patients attending a teaching dental hospital. A 7-year retrospective study from the United Arab Emirates |
| Q28583333 | Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis |
| Q26745482 | Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis |
| Q94563036 | Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease |
| Q56924599 | Systematic overview of hepatitis C infection in the Middle East and North Africa |
| Q58698247 | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
| Q26795711 | The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis |
| Q64982127 | The effectiveness of oral antiviral (Sofosbuvir/Ledipasvir) in treating children with HCV infection. |
| Q61796170 | The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses |
| Q47556282 | The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses |
| Q55130317 | The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. |
| Q63767002 | Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests |
Search more.